Literature DB >> 20864293

A comparison of the symptoms and short-term clinical course in inpatients with substance-induced psychosis and primary psychosis.

Sharon Dawe1, Leanne Geppert, Stefano Occhipinti, William Kingswell.   

Abstract

Relatively little is known about the clinical course of symptoms in patients with a substance-induced psychosis (SIP) compared with those with a primary psychotic disorder (PPD). In this study, symptoms associated with psychosis were monitored across admission in two groups of patients: those with SIP (amphetamines or cannabis; n = 47) and those with PPD (n = 51). Sixty-two percent of patients were first admissions, 23% had one previous admission, and a further 14% had had two previous admissions. Symptoms were monitored using the Brief Psychiatric Rating Scale. Scores on the positive symptoms scale, negative symptoms scale, manic excitement, and negative mood were reported as was the extent of observed disturbed behavior at admission and then at Days 4/5, 8/9, 15/16, 22/23, 29/30, 36/37, 43/44, and 50/51. Patients with a SIP experienced more severe mania and disturbed behavior at admission than those with a PPD. However, these symptoms abated more rapidly for the SIP group during admission. Although positive symptom scores were equally high at admission for both groups, there was a more rapid abatement of these symptoms in the SIP group. Finally, negative symptoms were lower in the SIP group at admission and at Days 50/51, although the decline in symptoms was comparable in both groups. Crown
Copyright © 2011. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20864293     DOI: 10.1016/j.jsat.2010.08.002

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  2 in total

Review 1.  Substance-induced Psychosis in Youth.

Authors:  David Beckmann; Kelsey Leigh Lowman; Jessica Nargiso; James McKowen; Lisa Watt; Amy M Yule
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2019-09-23

2.  Prediction of psychiatric comorbidity on premature death in a cohort of patients with substance use disorders: a 42-year follow-up.

Authors:  Mats Fridell; Martin Bäckström; Morten Hesse; Peter Krantz; Sean Perrin; Anna Nyhlén
Journal:  BMC Psychiatry       Date:  2019-05-15       Impact factor: 3.630

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.